4-Hydroxy-4-(2-hydroxyethyl)cyclohexan-1-one

Details

Top
Internal ID 6466ed13-d9d6-43a6-98df-4ef081f10a45
Taxonomy Organic oxygen compounds > Organooxygen compounds > Alcohols and polyols > Tertiary alcohols
IUPAC Name 4-hydroxy-4-(2-hydroxyethyl)cyclohexan-1-one
SMILES (Canonical) C1CC(CCC1=O)(CCO)O
SMILES (Isomeric) C1CC(CCC1=O)(CCO)O
InChI InChI=1S/C8H14O3/c9-6-5-8(11)3-1-7(10)2-4-8/h9,11H,1-6H2
InChI Key QLSFMYCHPVOSCD-UHFFFAOYSA-N
Popularity 7 references in papers

Physical and Chemical Properties

Top
Molecular Formula C8H14O3
Molecular Weight 158.19 g/mol
Exact Mass 158.094294304 g/mol
Topological Polar Surface Area (TPSA) 57.50 Ų
XlogP -0.20
Atomic LogP (AlogP) 0.24
H-Bond Acceptor 3
H-Bond Donor 2
Rotatable Bonds 2

Synonyms

Top
107389-91-3
4-hydroxy-4-(2-hydroxyethyl)cyclohexan-1-one
Cyclohexanone,4-hydroxy-4-(2-hydroxyethyl)-
4-hydroxy-4-(2-hydroxyethyl)cyclohexanone
Cyclohexanone, 4-hydroxy-4-(2-hydroxyethyl)-
starbld0000813
DTXSID00148032
AKOS032948564

2D Structure

Top
2D Structure of 4-Hydroxy-4-(2-hydroxyethyl)cyclohexan-1-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9506 95.06%
Caco-2 + 0.6916 69.16%
Blood Brain Barrier - 0.6750 67.50%
Human oral bioavailability + 0.6571 65.71%
Subcellular localzation Mitochondria 0.8856 88.56%
OATP2B1 inhibitior - 0.8510 85.10%
OATP1B1 inhibitior + 0.9498 94.98%
OATP1B3 inhibitior + 0.9528 95.28%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.7042 70.42%
BSEP inhibitior - 0.9084 90.84%
P-glycoprotein inhibitior - 0.9818 98.18%
P-glycoprotein substrate - 0.9795 97.95%
CYP3A4 substrate - 0.6508 65.08%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.7744 77.44%
CYP3A4 inhibition - 0.9161 91.61%
CYP2C9 inhibition - 0.7092 70.92%
CYP2C19 inhibition - 0.7655 76.55%
CYP2D6 inhibition - 0.9303 93.03%
CYP1A2 inhibition - 0.9060 90.60%
CYP2C8 inhibition - 0.9866 98.66%
CYP inhibitory promiscuity - 0.9620 96.20%
UGT catelyzed + 0.6362 63.62%
Carcinogenicity (binary) - 0.9600 96.00%
Carcinogenicity (trinary) Non-required 0.6776 67.76%
Eye corrosion - 0.9477 94.77%
Eye irritation + 0.9911 99.11%
Skin irritation - 0.7375 73.75%
Skin corrosion - 0.9619 96.19%
Ames mutagenesis - 0.7500 75.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7519 75.19%
Micronuclear - 0.9900 99.00%
Hepatotoxicity - 0.5251 52.51%
skin sensitisation - 0.8419 84.19%
Respiratory toxicity - 0.5667 56.67%
Reproductive toxicity - 0.6556 65.56%
Mitochondrial toxicity - 0.6000 60.00%
Nephrotoxicity + 0.5254 52.54%
Acute Oral Toxicity (c) III 0.7592 75.92%
Estrogen receptor binding - 0.9417 94.17%
Androgen receptor binding - 0.8341 83.41%
Thyroid receptor binding - 0.9130 91.30%
Glucocorticoid receptor binding - 0.8429 84.29%
Aromatase binding - 0.8233 82.33%
PPAR gamma - 0.8400 84.00%
Honey bee toxicity - 0.9539 95.39%
Biodegradation + 0.5750 57.50%
Crustacea aquatic toxicity - 0.8100 81.00%
Fish aquatic toxicity - 0.8213 82.13%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 93.97% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 87.90% 95.56%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 85.02% 96.09%
CHEMBL2581 P07339 Cathepsin D 84.53% 98.95%
CHEMBL4040 P28482 MAP kinase ERK2 82.77% 83.82%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 82.59% 94.45%

Cross-Links

Top
PubChem 184824
NPASS NPC263687
LOTUS LTS0018740
wikiData Q72461079